MustGrow Biologics Receives $1.5 Million From Exercise Of Warrants
MustGrow Biologics (CSE: MGRO) issued a brief news release this morning, indicating that it has bolstered company coffers via the
Read moreMustGrow Biologics (CSE: MGRO) issued a brief news release this morning, indicating that it has bolstered company coffers via the
Read moreKickstarting our short holiday week for the Daily Dive is that of Colin Bletsky, COO of MustGrow Biologics (CSE: MGRO).
Read moreMustGrow Biologics (CSE: MGRO) this morning had a major announcement, in that it has appointed Vice President and Chief Accounting
Read moreMustGrow Biologics (CSE: MGRO) this morning provided an update to the market on the status of its current product pipeline.
Read moreMustGrow Biologics (CSE: MGRO) has received the results from initial laboratory testing that was conducted in Colombia against the Panama
Read moreMustGrow Biologics (CSE: MGRO) is pushing forward with its focus on natural biopesticides, this morning announcing that it has obtained
Read moreMustGrow Biologics (CSE: MGRO) has begun testing its proprietary mustard-based formulation against Panama Disease, a pathogen that has been ravaging
Read moreIt appears that Bayer and the US government may have been undertaking some shady lobbying efforts in Thailand, according to
Read moreMustGrow Biologics (CSE: MGRO) this morning announced that it has strengthened its advisory team. The company has appointed seasoned global
Read moreMustGrow Biologics (CSE: MGRO) this morning released results from its successful greenhouse soil test results from testing its mustard-derived biopesticide
Read more